Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation. (2013)
Attributed to:
MICA: Convection-enhanced delivery of encapsulated nanospheres for controlled delivery of chemotherapy to the brain
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1212/wnl.0b013e3182a55ea5
PubMed Identifier: 23946313
Publication URI: http://europepmc.org/abstract/MED/23946313
Type: Journal Article/Review
Volume: 81
Parent Publication: Neurology
Issue: 13
ISSN: 0028-3878